Skip to main content
. 2012 Feb;8(1):6–13. doi: 10.2174/157340312801215818

Table 2.

Procedural and Lesion Characteristics*

Total (N=1020) Direct stenting (N=672) Stenting with pre-dilation (N=348) P value
Procedures 1099 704 395 -
Treated lesions 1.26±0.49 1.23±0.47 1.30±0.50 0.027
Timing of procedure
Elective
Urgent
Emergent

886 (80.6)
211 (19.2)
2 (0.2)

577 (82.0)
126 (17.9)
1 (0.1)

309 (78.2)
85 (21.5)
1 (0.3)
0.311
PCI of left main 15 (1.3) 5 (0.7) 10 (2.5) 0.013
PCI of left anterior descending 371 (33.8) 232 (33.0) 139 (35.2) 0.452
PCI of left circumflex 334 (30.4) 215 (30.5) 119 (30.1) 0.886
PCI of right coronary artery 458 (41.7) 290 (41.2) 168 (42.5) 0.666
PCI of other vessels 30 (2.7) 22 (3.1) 8 (2.0) 0.283
AHA/ACC type B2 or C lesion 487 (44.3) 223 (31.7) 264 (66.8) <0.001
Total occlusion 166 (15.1) 53 (7.5) 113 (28.6) <0.001
Ostial lesion 24 (2.2) 16 (2.3) 8 (2.0) 0.788
Bifurcation 96 (8.7) 46 (6.5) 50 (12.7) 0.001
Calcification 90 (8.2) 46 (6.5) 44 (11.1) 0.008
Tortuosity 255 (23.2) 181 (25.7) 74 (18.7) 0.009
Long lesion 261 (23.7) 118 (16.8) 143 (36.2) <0.001
Small vessel disease 438 (39.9) 238 (33.8) 200 (50.6) <0.001
Skylor™ stents 1292 818 474 -
Skylor™ stents per procedure 1.18±0.45 1.16±0.44 1.20±0.46 0.253
Skylor™ stent diameter 3.03±0.43 3.09±0.43 2.93±0.39 <0.001
Skylor™ stent length 19.5±10.3 17.9±9.1 22.5±11.4 <0.001
Post-dilation 54 (4.9) 28 (4.0) 26 (6.6) 0.055
Intravascular ultrasound 1 (0.1) 1 (0.1) 0 1.0
Procedural success 1083 (98.5) 695 (98.7) 388 (98.2) 0.512
Glycoprotein IIb/IIIa inhibitors 1013 (92.2) 654 (92.9) 359 (90.9) 0.233
Intra-aortic balloon pump 0 0 0 1.0
Dual antiplatelet therapy at discharge 1016 (99.6) 640 (99.4) 376 (100) 0.126
Duration of dual antiplatelet therapy (months) 13.3±5.9 13.3±5.9 13.4±5.7 0.762
*

reported as n (%) or mean±standard deviation; AHA/ACC=American College of Cardiology/American Heart Association; PCI=percutaneous coronary intervention